BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33361288)

  • 1. Antifungal Effect of All-
    Campione E; Gaziano R; Doldo E; Marino D; Falconi M; Iacovelli F; Tagliaferri D; Pacello L; Bianchi L; Lanna C; Aurisicchio L; Centofanti F; Di Francesco P; Del Principe I; Del Bufalo F; Locatelli F; Pistoia ES; Marra E; Orlandi A
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361288
    [No Abstract]   [Full Text] [Related]  

  • 2. Fungistatic activity of all-trans retinoic acid against Aspergillus fumigatus and Candida albicans.
    Campione E; Gaziano R; Marino D; Orlandi A
    Drug Des Devel Ther; 2016; 10():1551-5. PubMed ID: 27199548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of a low molecular weight antifungal protein from Penicillium chrysogenum (PAF) to treat pulmonary aspergillosis in mice.
    Palicz Z; Gáll T; Leiter É; Kollár S; Kovács I; Miszti-Blasius K; Pócsi I; Csernoch L; Szentesi P
    Emerg Microbes Infect; 2016 Nov; 5(11):e114. PubMed ID: 27826143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal Liposomes Directed by Dectin-2 Offer a Promising Therapeutic Option for Pulmonary Aspergillosis.
    Ambati S; Ellis EC; Pham T; Lewis ZA; Lin X; Meagher RB
    mBio; 2021 Feb; 12(1):. PubMed ID: 33622715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock protein 90 (Hsp90): A novel antifungal target against Aspergillus fumigatus.
    Lamoth F; Juvvadi PR; Steinbach WJ
    Crit Rev Microbiol; 2016; 42(2):310-21. PubMed ID: 25243616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal and antihepatotoxic effects of sepia ink extract against oxidative stress as a risk factor of invasive pulmonary aspergillosis in neutropenic mice.
    Fahmy SR; Soliman AM; Ali EM
    Afr J Tradit Complement Altern Med; 2014; 11(3):148-59. PubMed ID: 25371577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperbaric Oxygen Reduces Aspergillus fumigatus Proliferation
    Dhingra S; Buckey JC; Cramer RA
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29229641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimmune Responses in a New Experimental Animal Model of Cerebral Aspergillosis.
    Sullivan BN; Baggett MA; Guillory C; Jones M; Steele C
    mBio; 2022 Oct; 13(5):e0225422. PubMed ID: 36040029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosis.
    Ibrahim AS; Gebremariam T; French SW; Edwards JE; Spellberg B
    J Antimicrob Chemother; 2010 Feb; 65(2):289-92. PubMed ID: 19942619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of posaconazole and amphotericin B in experimental invasive pulmonary aspergillosis in dexamethasone immunosuppressed rats.
    Ullmann AJ; Krammes E; Sommer S; Buschmann I; Jahn-Muehl B; Cacciapuoti A; Schmitt HJ
    J Antimicrob Chemother; 2007 Nov; 60(5):1080-4. PubMed ID: 17855727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effects of pentoxifylline on invasive pulmonary aspergillosis in immunosuppressed mice.
    Feng C; Zhang M; Zhang S; Zhang J; Li C; Zhou J
    BMC Pulm Med; 2021 Jan; 21(1):31. PubMed ID: 33468116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.
    Walsh TJ; Petraitis V; Petraitiene R; Field-Ridley A; Sutton D; Ghannoum M; Sein T; Schaufele R; Peter J; Bacher J; Casler H; Armstrong D; Espinel-Ingroff A; Rinaldi MG; Lyman CA
    J Infect Dis; 2003 Jul; 188(2):305-19. PubMed ID: 12854088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics of the Orotomides against
    Hope WW; McEntee L; Livermore J; Whalley S; Johnson A; Farrington N; Kolamunnage-Dona R; Schwartz J; Kennedy A; Law D; Birch M; Rex JH
    mBio; 2017 Aug; 8(4):. PubMed ID: 28830945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APX001 Is Effective in the Treatment of Murine Invasive Pulmonary Aspergillosis.
    Gebremariam T; Alkhazraji S; Alqarihi A; Jeon HH; Gu Y; Kapoor M; Shaw KJ; Ibrahim AS
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posaconazole-Loaded Leukocytes as a Novel Treatment Strategy Targeting Invasive Pulmonary Aspergillosis.
    Baistrocchi SR; Lee MJ; Lehoux M; Ralph B; Snarr BD; Robitaille R; Sheppard DC
    J Infect Dis; 2017 Jun; 215(11):1734-1741. PubMed ID: 27799353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of NND-502, a novel imidazole antimycotic agent, in experimental models of Candida albicans and Aspergillus fumigatus infections.
    Niwano Y; Kuzuhara N; Goto Y; Munechika Y; Kodama H; Kanai K; Yoshida M; Miyazaki T; Yamaguchi H
    Int J Antimicrob Agents; 1999 Aug; 12(3):221-8. PubMed ID: 10461840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic interaction of the triple combination of amphotericin B, ciprofloxacin, and polymorphonuclear neutrophils against Aspergillus fumigatus.
    Stergiopoulou T; Meletiadis J; Sein T; Papaioannidou P; Walsh TJ; Roilides E
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5923-9. PubMed ID: 21911564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.
    Lewis RE; Liao G; Hou J; Chamilos G; Prince RA; Kontoyiannis DP
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1253-8. PubMed ID: 17261624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy.
    Hope WW; Kruhlak MJ; Lyman CA; Petraitiene R; Petraitis V; Francesconi A; Kasai M; Mickiene D; Sein T; Peter J; Kelaher AM; Hughes JE; Cotton MP; Cotten CJ; Bacher J; Tripathi S; Bermudez L; Maugel TK; Zerfas PM; Wingard JR; Drusano GL; Walsh TJ
    J Infect Dis; 2007 Feb; 195(3):455-66. PubMed ID: 17205486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with micafungin and amphotericin B for invasive pulmonary aspergillosis in an immunocompromised mouse model.
    Nagasaki Y; Eriguchi Y; Uchida Y; Miyake N; Maehara Y; Kadowaki M; Harada M; Akashi K; Shimono N
    J Antimicrob Chemother; 2009 Aug; 64(2):379-82. PubMed ID: 19465436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.